NeuBase Therapeutics, Inc. NBSE
Set alert
0.38 +0.38 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 1.42M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.03
- Beta
- 0.94
- Short ratio
- 0.24
- Inst. own
- 11.87%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 26, 2024
- 50-d avg
- 0.472587
- 200-d avg
- 0.722122
- 1y target
- 0.00
2Y chart
Events in this range
- Jun 15, 2023Split: 1 for 20
- Aug 14, 2023Earnings: -1.26; estimate -1.8; surprise 30%
- Nov 9, 2023Earnings: -0.95; estimate -1.82; surprise 47.8%
Signals (75)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Apr 18, 2024 | 2 years ago |
| RSI: Oversold | Apr 16, 2024 | 2 years ago |
| SMA: Bearish | Mar 26, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 26, 2024 | 2 years ago |
| RSI: Oversold | Mar 26, 2024 | 2 years ago |
| RSI: Overbought | Mar 18, 2024 | 2 years ago |
| RSI: Overbought | Feb 26, 2024 | 2 years ago |
| SMA: Bullish | Feb 16, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 29, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 11, 2024 | 2 years ago |
| SMA: Bearish | Jan 9, 2024 | 2 years ago |
| SMA: Bullish | Jan 5, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 4, 2024 | 2 years ago |
| SMA: Bearish | Jan 2, 2024 | 2 years ago |
| SMA: Bullish | Dec 29, 2023 | 2 years ago |
| SMA: Bearish | Dec 13, 2023 | 2 years ago |
| MACD: Sell Signal | Dec 13, 2023 | 2 years ago |
| RSI: Overbought | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 30, 2023 | 2 years ago |
| RSI: Overbought | Nov 30, 2023 | 2 years ago |
| MACD: Buy Signal | Oct 30, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 27, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 16, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 20, 2023 | 3 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| SMA: Bullish | Sep 14, 2023 | 3 years ago |
| SMA: Bearish | Sep 13, 2023 | 3 years ago |
| SMA: Bullish | Sep 6, 2023 | 3 years ago |
| RSI: Overbought | Sep 6, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 17, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 3, 2023 | 3 years ago |
| RSI: Oversold | Jul 24, 2023 | 3 years ago |
| RSI: Oversold | Jul 14, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 13, 2023 | 3 years ago |
| RSI: Oversold | Jun 26, 2023 | 3 years ago |
| RSI: Oversold | Jun 15, 2023 | 3 years ago |
| SMA: Bearish | Jun 14, 2023 | 3 years ago |
| MACD: Sell Signal | May 26, 2023 | 3 years ago |
| SMA: Bullish | May 5, 2023 | 3 years ago |
| MACD: Buy Signal | May 3, 2023 | 3 years ago |
| RSI: Oversold | Apr 25, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 24, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 30, 2023 | 3 years ago |
| SMA: Bearish | Feb 24, 2023 | 3 years ago |
| SMA: Bullish | Feb 22, 2023 | 3 years ago |
| SMA: Bearish | Feb 21, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 21, 2023 | 3 years ago |
| RSI: Overbought | Feb 10, 2023 | 3 years ago |
| MACD: Buy Signal | Feb 9, 2023 | 3 years ago |
| SMA: Bullish | Jan 31, 2023 | 3 years ago |
| SMA: Bearish | Jan 30, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 27, 2023 | 3 years ago |
| SMA: Bullish | Jan 12, 2023 | 3 years ago |
| SMA: Bearish | Jan 11, 2023 | 3 years ago |
| SMA: Bullish | Jan 10, 2023 | 3 years ago |
| SMA: Bearish | Jan 9, 2023 | 3 years ago |
| SMA: Bullish | Jan 6, 2023 | 3 years ago |
| MACD: Buy Signal | Dec 12, 2022 | 3 years ago |
| MACD: Sell Signal | Dec 9, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 11, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 10, 2022 | 3 years ago |
| RSI: Oversold | Nov 9, 2022 | 3 years ago |
| RSI: Oversold | Oct 21, 2022 | 4 years ago |
| RSI: Oversold | Oct 19, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 28, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 21, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 15, 2022 | 4 years ago |
| RSI: Oversold | Aug 31, 2022 | 4 years ago |
| RSI: Oversold | Aug 23, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 16, 2022 | 4 years ago |
| RSI: Overbought | Aug 4, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 29, 2022 | 4 years ago |
| MACD: Sell Signal | Jul 28, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 27, 2022 | 4 years ago |
| MACD: Sell Signal | Jul 26, 2022 | 4 years ago |
Key statistics
- Market cap
- 1.42M
- Enterprise value
- -5.83M
- Trailing P/E
- 0.00
- Forward P/E
- -0.03
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.15
- EPS (TTM)
- -18.60
- Beta
- 0.94
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -15.18M
- Total cash
- 12.57M
- Total debt
- 5.34M
- Return on equity
- -93.46%
- Shares outstanding
- 3.75M
- Short % of float
- 0.44%
- 50-day average
- 0.472587
- 200-day average
- 0.722122
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Next earnings
Dec 26, 2024
Expected Dec 26, 2024. Consensus EPS estimate 0.00.
Financials — quick view
NBSE Revenue — quarterly 0
NBSE Net income — quarterly -1.82M
NBSE EPS — quarterly -0.66
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 26, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Sep 30, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 4, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Nov 9, 2023 | Sep 1, 2023 | -1.82 | -0.95 | +0.87 | +47.80% |
| Aug 14, 2023 | Jun 1, 2023 | -1.80 | -1.26 | +0.54 | +30.00% |
About NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- neubasetherapeutics.com
News
- NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Cheap Penny Stocks To Buy Now? 3 For Your Watch List
- NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder
- NeuBase (NBSE) Surges 107% on New Shareholder Acquiring Stake
- Why Is NeuBase Therapeutics (NBSE) Stock Down 27% Today?
- SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
Your note
Sign in to keep a note on NBSE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALMENOFF JUNE SHERIE | Director | Purchase | Feb 5, 2015 | 16,900 |
| BACKENROTH SAMUEL | Chief Financial Officer | Purchase | Apr 29, 2020 | 11,630 |
| BRANNING TODD P | Chief Financial Officer | Stock Award(Grant) | Mar 15, 2023 | 84,200 |
| GOLDSTEIN DOV A | Director | Purchase | Jun 17, 2021 | 30,000 |
| HIRSCHMAN ORIN | Director | Purchase | Apr 9, 2017 | 0 |
| MANN WILLIAM ROLAND | Chief Operating Officer | Purchase | Mar 29, 2022 | 11,200 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 7.03% | 166,174 | 310.75K | Jun 29, 2023 |
| Greenlight Capital, Inc. | 5.77% | 136,350 | 254.97K | Jun 29, 2023 |
| Point72 Asset Management, L.P. | 2.65% | 62,500 | 116.88K | Jun 29, 2023 |
| Decheng Capital Management III (Cayman), LLC | 2.12% | 50,000 | 93.50K | Jun 29, 2023 |
| Carnegie Mellon University | 1.99% | 46,970 | 87.83K | Jun 29, 2023 |
| Kestra Advisory Services, LLC | 1.08% | 25,483 | 47.65K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.80% | 18,981 | 35.49K | Jun 29, 2023 |
| Jacob Discovery Fd | 0.66% | 15,655 | 15.19K | Aug 30, 2023 |
| Fidelity Extended Market Index Fund | 0.30% | 7,081 | 25.22K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.06% | 1,425 | 5.08K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.06% | 1,359 | 4.84K | May 30, 2023 |
| Schwab Capital Trust-Total Stock Market Index Fund | 0.06% | 1,485 | 2.06K | Jul 30, 2023 |